BiomX Stock (AMEX: PHGE) stock price, news, charts, stock research, profile.
Open | $0.282 |
Close | $0.290 |
Volume / Avg. | 69.439K / 2.572M |
Day Range | 0.280 - 0.298 |
52 Wk Range | 0.187 - 0.855 |
Market Cap | $16.014M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 43 |
Short Interest | 0.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BiomX (AMEX: PHGE) through any online brokerage.
Other companies in BiomX’s space includes: Vincerx Pharma (NASDAQ:VINC), Eterna Therapeutics (NASDAQ:ERNA), NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO) and Immuron (NASDAQ:IMRN).
The latest price target for BiomX (AMEX: PHGE) was reported by HC Wainwright & Co. on Wednesday, April 3, 2024. The analyst firm set a price target for 2.00 expecting PHGE to rise to within 12 months (a possible 567.33% upside). 5 analyst firms have reported ratings in the last year.
The stock price for BiomX (AMEX: PHGE) is $0.2997 last updated Today at April 19, 2024 at 9:26 AM EDT.
There are no upcoming dividends for BiomX.
BiomX’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for BiomX.
BiomX is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.